1. I12 Rituximab for refractory manifestations of the antiphospholipid syndrome – the israeli experience. (23rd March 2020) Authors: Agmon-Levin, Nancy; Berman, Mark; Harel, Liora; Yahia, Soad Haj; Lidar, Merav; Paran, Daphna Journal: Lupus science & medicine Issue: Volume 7(2020)Supplement 1 Page Start: A6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗